G. Schett

976 total citations
51 papers, 644 citations indexed

About

G. Schett is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, G. Schett has authored 51 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Rheumatology, 15 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in G. Schett's work include Rheumatoid Arthritis Research and Therapies (14 papers), Spondyloarthritis Studies and Treatments (8 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). G. Schett is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (14 papers), Spondyloarthritis Studies and Treatments (8 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). G. Schett collaborates with scholars based in Germany, United States and Austria. G. Schett's co-authors include Jochen Zwerina, Martin Herrmann, Sandra Franz, Jürgen Rech, Josef S Smolen, Mario M. Zaiss, Sonja Herman, K Polzer, Roland Axmann and Christina Bergmann and has published in prestigious journals such as Blood, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

G. Schett

43 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Schett Germany	12	257	248	246	111	99	51	644
Katarzyna Romanowska‐Próchnicka Poland	14	186 0.7×	142 0.6×	230 0.9×	77 0.7×	81 0.8×	37	644
Haruka Tsuchiya Japan	14	188 0.7×	111 0.4×	196 0.8×	69 0.6×	80 0.8×	31	512
Yoshie Sanayama Japan	10	332 1.3×	79 0.3×	171 0.7×	95 0.9×	62 0.6×	17	582
Румен Стоилов Bulgaria	12	287 1.1×	79 0.3×	223 0.9×	112 1.0×	78 0.8×	45	542
Beáta Dérfalvi Canada	14	144 0.6×	193 0.8×	271 1.1×	140 1.3×	46 0.5×	37	644
Rasho Rashkov Bulgaria	12	250 1.0×	74 0.3×	173 0.7×	47 0.4×	66 0.7×	47	475
Patricia Moya Spain	14	253 1.0×	128 0.5×	101 0.4×	108 1.0×	66 0.7×	65	565
Anfisa Stanevsky Israel	10	160 0.6×	89 0.4×	272 1.1×	131 1.2×	52 0.5×	13	543
Clara Di Mario Italy	14	190 0.7×	103 0.4×	141 0.6×	47 0.4×	32 0.3×	39	473
Yuya Fujita Japan	14	224 0.9×	185 0.7×	254 1.0×	55 0.5×	71 0.7×	78	554

Countries citing papers authored by G. Schett

Since Specialization

Citations

This map shows the geographic impact of G. Schett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Schett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Schett more than expected).

Fields of papers citing papers by G. Schett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Schett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Schett. The network helps show where G. Schett may publish in the future.

Co-authorship network of co-authors of G. Schett

This figure shows the co-authorship network connecting the top 25 collaborators of G. Schett. A scholar is included among the top collaborators of G. Schett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Schett. G. Schett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Chang, Ioanna Minopoulou, Giulia Corte, et al.. (2025). Advancement and independent validation of a deep learning-based tool for automated scoring of nail psoriasis severity using the modified nail psoriasis severity index. Frontiers in Medicine. 12. 1574413–1574413. 1 indexed citations

Atzinger, Armin, Koray Taşçılar, Arnd Kleyer, et al.. (2025). Synovial fibroblast activation occurs before the onset of rheumatoid arthritis and influences the risk of developing disease. RMD Open. 11(4). e005775–e005775.

Heidinger, Martin, Clemens Lang, Julia Ferrari, et al.. (2025). The risk of femoral fracture is increased in patients with ischemic stroke and transient ischemic attack—a population-based observational secondary analysis of the Austrian stroke cohort. International Journal of Stroke. 21(2). 275–283.

Tripal, Philipp, Stefanie Weber, Maria Gabriella Raimondo, et al.. (2025). Matrix stiffness regulates profibrotic fibroblast differentiation and fibrotic niche activation in systemic sclerosis. Annals of the Rheumatic Diseases. 84(11). 1865–1876.

Smarr, Benjamin L., Sara Bayat, Arnd Kleyer, et al.. (2025). A robust machine learning approach to predicting remission and stratifying risk in rheumatoid arthritis patients treated with bDMARDs. Scientific Reports. 15(1). 23960–23960. 1 indexed citations

Garantziotis, Panagiotis, Janina Auth, G. Schett, & Christina Bergmann. (2025). CAR T-cell therapy in systemic sclerosis: the next frontier in immune modulation. Current Opinion in Rheumatology. 38(1). 60–68.

Minopoulou, Ioanna, Filippo Fagni, Armin Atzinger, et al.. (2025). Unconventional Imaging Methods in Psoriatic Arthritis. Current Rheumatology Reports. 27(1). 13–13. 1 indexed citations

Taubmann, Jule, Sebastian Boeltz, Melanie Hagen, et al.. (2025). Langzeitverlauf von Effizienz und Sicherheit der CD19-CAR T-Zell-Therapie beim systemischen Lupus erythematodes. Zeitschrift für Rheumatologie. 84(8). 612–620. 1 indexed citations

Coates, Laura C., et al.. (2024). OP0195 EFFICACY AND SAFETY OF SONELOKIMAB, A NOVEL IL-17A- AND IL-17F-INHIBITING NANOBODY®, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS (PsA): RESULTS FROM THE GLOBAL, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 ARGO TRIAL. Annals of the Rheumatic Diseases. 83. 154–155. 6 indexed citations

10.

Siebert, Stefan, G. Schett, S. P. Raychaudhuri, et al.. (2024). Correlation of changes in inflammatory and collagen biomarkers with durable guselkumab efficacy through 2 years in participants with active psoriatic arthritis: results from a phase III randomized controlled trial. Therapeutic Advances in Musculoskeletal Disease. 16. 1759720X241283536–1759720X241283536. 2 indexed citations

11.

Liphardt, Anna‐Maria, Cristina Bouzas, Pascal Petit, et al.. (2024). Impact of the digital health application ViViRA on spinal mobility, physical function, quality of life and pain perception in spondyloarthritides patients: a randomized controlled trial. Arthritis Research & Therapy. 26(1). 208–208. 3 indexed citations

12.

Regierer, Anne C., Denis Poddubnyy, Frank Behrens, et al.. (2021). POS0296 DOSING OF BDMARDS IN AXSPA AND PSA IN A REAL WORLD SETTING. Annals of the Rheumatic Diseases. 80. 373–373.

13.

Derer, Anja, Christina Böhm, Bettina Grötsch, et al.. (2014). Rsk2 controls synovial fibroblast hyperplasia and the course of arthritis. Annals of the Rheumatic Diseases. 75(2). 413–421. 19 indexed citations

14.

Dougados, Maxime, K. Kissel, Philip G. Conaghan, et al.. (2012). Clinical, Radiographic, and Immunogenic Effects After 1 Year of Tocilizumab-Based Treatment Strategy with and without Methotrexate in Rheumatoid Arthritis: The ACT-RAY Study. Data Archiving and Networked Services (DANS). 64(10). 6 indexed citations

15.

Dougados, Maxime, K. Kissel, Howard Amital, et al.. (2011). Double-Blind Study of Tocilizumab Plus Methotrexate Vs Tocilizumab Plus Placebo in Patients with Active Rheumatoid Arthritis Despite Prior Methotrexate : Progression of Structural Damage, Quality of Life, and Physical Function At 24 Weeks.. Data Archiving and Networked Services (DANS). 63(10). 28–29. 6 indexed citations

16.

Rech, Jürgen, Bernhard Manger, Bianca Lang, et al.. (2011). Adult-onset Still’s disease and chronic recurrent multifocal osteomyelitis: a hitherto undescribed manifestation of autoinflammation. Rheumatology International. 32(6). 1827–1829. 20 indexed citations

17.

Axmann, Roland, Sonja Herman, Mario M. Zaiss, et al.. (2008). CTLA-4 directly inhibits osteoclast formation. Annals of the Rheumatic Diseases. 67(11). 1603–1609. 152 indexed citations

18.

Wöhrer, Stefan, Marlene Troch, Jochen Zwerina, et al.. (2007). Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases. Annals of Oncology. 18(4). 647–651. 14 indexed citations

19.

Muñoz, Luis E., Sandra Franz, Reinhard Voll, et al.. (2007). IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of systemic lupus erythaematosus sera. Annals of the Rheumatic Diseases. 67(11). 1626–1632. 28 indexed citations

20.

Schett, G., Silvia Hayer, M Tohidast-Akrad, et al.. (2001). Adenovirus-based overexpression of tissue inhibitor of metalloproteinases 1 reduces tissue damage in the joints of tumor necrosis factor ? transgenic mice. Arthritis & Rheumatism. 44(12). 2888–2898. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact